维普期刊资源整合服务平台（V6.5）

70篇 您的检索式：作者名="Reigner"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	An improved forced - vibration teehnique for measurements of materials damping 显示文摘	Gibson RF Yau A Reigner DA	1982	Exp Teeh1982，6，2：	1
2	Preliminary studies of a novel oral fluoropyrimidine carbamate:capecitabine显示文摘	Budman DR Meropol NJ Reigner B	1998	J Clin Oncol1998，16，6：	1
3	Preliminary studiesof a novel oral fluoropy rimidine carbamate:capecitabline显示文摘	Budman D R Meropd N J Reigner B	1998	JClin Oncol1998，16，6：	1
4	Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer 显示文摘	Camidge R Reigner B Cassidy J	2005	J Clin Oncol2005，23，47：	1
5	An improved forced-vibration technique for measurements of materials damping显示文摘	Gibson R F Yau A Reigner D A	1982	Exp Techn1982，6，2：	1
6	Population Pharmacorkinetic analysis of the major metabolites of capecitabine显示文摘	Reigner B Blesch KS	2002	J Pharmacokinet Pharmacodyn2002，29，1：	1
7	Population pharmacokinetic analysis of the major metabolites of capecitabine显示文摘	Gieschike R Reigner B Blesch KS	2002	I pharmacokinet pharmacodyn2002，29，1：	1
8	Effect of food on the pharmacokinetics of capecitabine and its metabolizes following oral administration in cancer patients显示文摘	Reigner B Verweij J Dirix L	1998	Clin Cancer Res1998，4，4：	1
9	Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer显示文摘	Camidge R Reigner B Cassidy J	2005	J Clin Oncol2005，23，21：	1
10	Population pharmacokinetic analysis of the major metabolites of capecitabine 显示文摘	Gieschke R Reigner B Blesch KS	2002	J Pharmacokinet pharmacodyn2002，29，1：	1
11	Clinicalpharmacokinetics of capecitabine显示文摘	REIGNER B BLESCH K WEIDEKAMM E	2001	ClinPharmacokinet2001，40，2：	1
12	Effect offood on the pharmacokinetics of capecitabineand its metabolites following oral administrationin cancer patients显示文摘	REIGNER B VERWEIJ J DIRIX L		Clin Cancer Res'' 1 9980，4，4：	1
13	Contribution of PAR-1, PAR-4 and GPlbalpha in intracellular signaling leading to the cleavage of the beta3 cytoplasmic domain during thrombin-induced platelet aggregation显示文摘	DUBOIS C STEINER B MEYER REIGNER SC	2004	Thromb Haemost2004，91，4：	1
14	Influenceof the antacid Maalox on the pharmacokineticsof capecitabine in cancer patients显示文摘	REIGNER B CLIVE S CASSIDY J		CancerChemother Pharmacol0，43，4：	1
15	Population Pharmacorkinetic analysis of the major metabolites of capecitabine显示文摘	Reigner B Blesch KS	2002	J Pharmacokinet Pharmacodyn2002，29，1：	1
16	Capecitabine a Review of Its Clinical Pharmacokinetics显示文摘	Reigner B Blesch K Weidekamm E	2001	Clin Pharmacokinet2001，40，2：	1
17	Fuzzy logic technique for mobile robot obstacle avoidance显示文摘	REIGNER P	1994	Robotics and Autonomous System1994，12，2：	1
18	Preliminary studies of a novel oralfluoropyrimidine carbamate: capecitabine显示文摘	BUDMAN D R MEROPOL N J REIGNER B	1998	CUnOncol1998，16，5：	1
19	Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer 显示文摘	Camidge R Reigner B Cassidy J	2005	J Clin Oncol2005，23，21：	1
20	Preliminary studies of a novel oral fluoropyrimidine carbamate:capecitabine显示文摘	Meropol NJ Reigner B	1998	J Clin Oncol1998，16，6：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示